Pulmonary Stents Market Size, Share & Industry Analysis, By Product (Self-expandable, Balloon-expandable), By Material (Metal, Silicon, Hybrid), By Type (Tracheobronchial Stents, Laryngeal Stents), and Regional Forecast, 2026-2034

The global pulmonary stents market size was valued at USD 246.18 Million in 2025. The market is projected to grow from USD 258.42 Million in 2026 to USD 381.05 Million by 2034, exhibiting a CAGR of 4.97% during the forecast period.

The pulmonary stents market is expanding steadily due to the increasing prevalence of respiratory disorders, airway obstruction diseases, tracheobronchial complications, and lung-related chronic conditions. Pulmonary stents are widely used to maintain airway patency in patients suffering from malignant and benign airway stenosis. Technological improvements in minimally invasive pulmonary procedures, enhanced bronchoscopy systems, and growing hospital adoption of interventional pulmonology are contributing to market expansion. The pulmonary stents market Report highlights increasing demand for self-expandable and hybrid stents that provide improved flexibility, patient comfort, and long-term airway support. Healthcare providers are emphasizing customized pulmonary stent solutions to improve clinical outcomes and reduce procedural complications.

The United States pulmonary stents market remains one of the leading contributors globally due to advanced healthcare infrastructure, increasing respiratory disease burden, and strong adoption of minimally invasive procedures. Growing cases of chronic obstructive pulmonary disease, lung cancer, tracheal stenosis, and post-transplant airway complications continue to drive demand for pulmonary stents across hospitals and specialty pulmonary centers. The market is supported by favorable reimbursement systems, advanced diagnostic technologies, and ongoing innovation in airway management devices. Increasing investments in interventional pulmonology programs and rising awareness regarding early airway intervention are further strengthening market penetration throughout the United States healthcare sector.

Pulmonary Stents Market Key Takeaways

 Global Market Size & Forecast

• 2025 Market Size: USD 246.18 Million
• 2026 Market Size: USD 258.42 Million
• 2034 Forecast Market Size: USD 381.05 Million
• CAGR: 4.97% from 2026-2034

Market Share

• The market in North America dominated with a revenue share of 39% in 2025.
• Self-expandable pulmonary stents dominated by product with a market share of approximately 64%.
• Metal pulmonary stents dominated by material with a market share of approximately 38%.

Key Regional Highlights

North America

North America led the market with a 39% share, supported by advanced respiratory care and growing adoption of minimally invasive airway procedures.

Europe

Europe accounted for 28% of the market, driven by established healthcare infrastructure and increasing demand for pulmonary interventions.

Asia-Pacific

Asia-Pacific held a 25% share, supported by expanding healthcare infrastructure and rising awareness of advanced airway treatments.

U.S

The U.S. remains a key market, supported by advanced pulmonary care and growing adoption of bronchoscopic interventions.

Japan

Japan accounted for approximately 19% of the Asia-Pacific market, supported by advanced healthcare infrastructure and growing demand for respiratory care.

Read More

Pulmonary Stents Market Latest Trends

The pulmonary stents market trends indicate a growing shift toward customized and patient-specific pulmonary stent solutions. Manufacturers are developing advanced stents with enhanced biocompatibility, anti-migration properties, and improved flexibility to support complex airway anatomies. Three-dimensional imaging and precision-guided bronchoscopy techniques are increasingly being integrated into pulmonary stent placement procedures to improve procedural accuracy and patient outcomes.

Download Free sample to learn more about this report.

Another significant trend in the pulmonary stents market Analysis is the increasing use of hybrid and silicone-based pulmonary stents designed to minimize tissue irritation and improve long-term performance. Healthcare facilities are adopting minimally invasive bronchoscopic interventions that reduce recovery time and procedural complications. In addition, rising clinical research activities focused on bioresorbable pulmonary stents and drug-eluting airway stents are generating new growth opportunities. The Pulmonary Stents Industry Report also highlights increased collaboration between medical device manufacturers and pulmonary care centers to accelerate innovation in respiratory intervention technologies.

Pulmonary Stents Market Dynamics

Driver

Increasing Prevalence of Chronic Respiratory Disorders and Airway Obstruction Diseases

The primary driver supporting pulmonary stents market growth is the rising incidence of respiratory diseases that require airway stabilization and intervention. Conditions such as chronic obstructive pulmonary disease, tracheal stenosis, lung cancer, bronchial obstruction, and post-surgical airway narrowing are increasing globally due to aging populations, smoking prevalence, environmental pollution, and occupational exposure to harmful particles. Pulmonary stents are becoming essential tools in maintaining airway patency and improving patient breathing function.

Healthcare providers are increasingly adopting minimally invasive bronchoscopic procedures to treat respiratory complications with reduced surgical trauma and faster patient recovery. Pulmonary stents provide immediate airway relief and are frequently used in both malignant and benign airway disorders. Technological advancements in self-expandable and hybrid pulmonary stents are improving clinical outcomes and patient comfort. Rising investments in respiratory healthcare infrastructure and increasing awareness regarding advanced airway management continue to strengthen the pulmonary stents market outlook across developed and emerging healthcare systems.

Restraint

Risk of Stent Migration and Post-Procedural Complications

One of the major restraints within the pulmonary stents market is the occurrence of complications associated with pulmonary stent implantation. Patients may experience stent migration, granulation tissue formation, mucus accumulation, infection, and airway irritation following stent placement procedures. These complications can increase hospitalization rates and require repeated interventions, limiting widespread adoption in certain patient populations.

Healthcare professionals often require specialized training and advanced bronchoscopic expertise to perform pulmonary stent procedures effectively. Limited availability of skilled interventional pulmonologists in some regions creates operational challenges for hospitals and specialty clinics. In addition, concerns regarding long-term patient management and follow-up monitoring may discourage adoption among smaller healthcare facilities. High device costs and procedural expenses also remain barriers in developing healthcare systems where access to advanced respiratory interventions is limited.

Opportunity

Expansion of Minimally Invasive Interventional Pulmonology Procedures

The pulmonary stents market opportunities landscape is expanding due to increasing demand for minimally invasive respiratory procedures. Hospitals and specialty pulmonary centers are focusing on bronchoscopic interventions that reduce surgical trauma, shorten hospital stays, and improve patient recovery times. This trend is creating substantial opportunities for advanced pulmonary stent technologies with improved flexibility, durability, and biocompatibility.

Manufacturers are investing in research related to bioresorbable pulmonary stents, personalized airway devices, and next-generation silicone stents designed for complex respiratory conditions. Emerging healthcare markets are also increasing investments in respiratory care infrastructure and interventional pulmonology programs. Growing awareness regarding early diagnosis and treatment of airway disorders is expected to support long-term demand. Strategic collaborations between medical device companies and healthcare providers are accelerating product development and commercialization opportunities within the pulmonary stents market research report ecosystem.

Challenge

Regulatory Complexities and High Clinical Validation Requirements

A significant challenge impacting the Pulmonary Stents industry analysis is the strict regulatory environment governing respiratory medical devices. Pulmonary stents require extensive clinical validation, safety testing, and regulatory approval processes before commercialization. These procedures can increase development timelines and operational costs for manufacturers.

The market also faces challenges related to standardization of airway stent procedures and long-term patient monitoring requirements. Differences in airway anatomy and disease severity often require customized solutions, increasing manufacturing complexity. Smaller manufacturers may struggle to compete with larger medical device companies possessing extensive research capabilities and global regulatory expertise. Furthermore, maintaining product quality, biocompatibility, and long-term performance consistency remains a critical operational challenge for industry participants.

Pulmonary Stents Market Segmentation

By Product

Self-expandable pulmonary stents account for approximately 64% of the pulmonary stents market share due to their flexibility, ease of deployment, and ability to conform to irregular airway structures. These stents are widely used in treating malignant airway obstruction, tracheobronchial stenosis, and post-surgical airway narrowing. Self-expandable pulmonary stents provide continuous radial force that helps maintain airway patency while reducing the risk of airway collapse. Healthcare providers prefer self-expandable stents because they can often be inserted using minimally invasive bronchoscopic techniques. Their adaptability to complex anatomical structures supports improved patient outcomes and procedural efficiency. Manufacturers are continuously enhancing self-expandable pulmonary stents through advanced metal alloys, anti-migration designs, and improved biocompatibility coatings.

Balloon-expandable pulmonary stents represent approximately 36% of the pulmonary stents market size and remain important for precise airway interventions requiring controlled expansion. These stents are commonly utilized in patients requiring accurate stent placement within localized airway strictures and post-transplant complications. Balloon-expandable designs provide physicians with enhanced positioning control during deployment procedures. This segment benefits from ongoing advancements in catheter-based respiratory interventions and imaging technologies. Balloon-expandable pulmonary stents are increasingly manufactured using lightweight materials that improve flexibility while maintaining structural integrity.

To know how our report can help streamline your business, Speak to Analyst

By Material

Metal pulmonary stents account for approximately 38% of the pulmonary stents market due to their strong radial force, durability, and long-term airway stabilization capabilities. These stents are commonly used in severe airway obstruction cases involving malignant tumors and complex tracheobronchial conditions. Metal pulmonary stents provide structural reinforcement while supporting continuous airflow improvement. The segment is supported by advancements in nitinol and stainless-steel alloy technologies that improve flexibility and biocompatibility. Self-expandable metal stents are particularly popular in interventional pulmonology due to ease of deployment and adaptability to varying airway anatomies. Manufacturers are also developing coated metal stents to reduce tissue irritation and minimize granulation formation.

Silicon pulmonary stents hold approximately 24% of the pulmonary stents market share and are widely recognized for their biocompatibility and removability. These stents are frequently used in benign airway disorders where temporary airway stabilization is required. Silicone-based pulmonary stents minimize tissue reaction and are often preferred in patients requiring long-term airway management. The segment benefits from ongoing improvements in silicone molding technologies and customized airway device manufacturing. Silicone pulmonary stents are increasingly utilized in tracheal stenosis management and post-intubation airway complications. Their flexibility and smooth surface design help reduce patient discomfort and mucus accumulation. Healthcare providers often favor silicone stents in cases where future stent removal or replacement may become necessary. 

By Type

Hybrid pulmonary stents represent approximately 14% of the Pulmonary Stents Industry and combine features of metal and silicone stents to optimize flexibility, stability, and patient compatibility. These stents are designed to minimize migration risks while improving airway support in complex respiratory cases. Manufacturers are increasingly developing hybrid pulmonary stents with advanced coatings and adaptive structural designs. The segment is gaining attention among healthcare providers treating complicated tracheobronchial conditions that require both flexibility and strong airway stabilization. Hybrid stents also support improved patient comfort and reduced procedural complications. Rising demand for customized airway management devices and increasing technological innovation continue to create growth opportunities for this segment.

Tracheobronchial stents account for approximately 17% of the pulmonary stents market and are extensively utilized in treating airway narrowing involving the trachea and bronchi. These stents provide airway stabilization in patients suffering from malignant airway obstruction, tracheal collapse, and post-surgical complications. The segment benefits from increasing adoption of bronchoscopy-guided respiratory interventions and growing clinical expertise in airway management procedures. Manufacturers are introducing advanced tracheobronchial stents with improved flexibility and anti-migration characteristics. Hospitals are investing in specialized pulmonary intervention programs to improve treatment outcomes for respiratory patients. Demand for tracheobronchial stents continues to rise due to increasing respiratory disease prevalence and expanding awareness regarding minimally invasive airway treatment options.

Laryngeal stents represent approximately 7% of the pulmonary stents market Insights landscape. These devices are used primarily in patients experiencing laryngeal narrowing, post-surgical airway complications, and congenital airway abnormalities. Laryngeal stents support airway stability while preserving vocal function and respiratory airflow. Manufacturers are developing lightweight and anatomically compatible laryngeal stents designed to improve patient comfort and reduce irritation risks. Pediatric airway management applications are also contributing to segment demand. Healthcare providers increasingly utilize laryngeal stents in specialized otolaryngology and respiratory care settings.

Pulmonary Stents Market Regional Outlook

To get more information on the regional analysis of this market, Download Free sample

North America

North America remains a dominant region in the pulmonary stents market due to strong healthcare infrastructure, increasing prevalence of respiratory disorders, and rapid adoption of minimally invasive airway management procedures. The region accounted for 39% of the global pulmonary stents market , supported by rising demand for advanced bronchoscopy-guided interventions across hospitals and specialty pulmonary centers. Increasing cases of chronic obstructive pulmonary disease, lung cancer, tracheal stenosis, and post-surgical airway complications continue to create strong demand for pulmonary stents throughout the United States and Canada. Healthcare providers are increasingly focusing on early respiratory disease diagnosis and advanced airway stabilization procedures to improve patient outcomes.

The pulmonary stents market Report highlights growing investments in respiratory healthcare innovation and advanced pulmonary intervention technologies throughout North America. Medical device manufacturers are introducing highly flexible and biocompatible pulmonary stents designed to reduce migration risks and improve long-term airway patency. The region also benefits from strong reimbursement systems, advanced research facilities, and highly skilled interventional pulmonologists. Increasing awareness regarding minimally invasive respiratory procedures and rising adoption of customized pulmonary stent solutions continue to strengthen North America’s position within the global Pulmonary Stents industry analysis.

Europe

Europe represents one of the most technologically advanced regions within the pulmonary stents market due to increasing respiratory disease prevalence and strong healthcare modernization initiatives. The region contributed 28% of the global pulmonary stents market share, driven by growing adoption of minimally invasive pulmonary procedures and advanced airway management systems. Countries across Europe are investing heavily in bronchoscopy technologies, respiratory intervention centers, and clinical research programs focused on improving treatment outcomes for airway obstruction disorders. Rising elderly population and increasing incidence of chronic pulmonary diseases are further supporting market growth.

The pulmonary stents market outlook indicates that European healthcare providers are emphasizing patient safety, precision medicine, and customized respiratory treatment approaches. Manufacturers operating in the region are focusing on innovative pulmonary stent designs with improved flexibility, anti-migration properties, and enhanced biocompatibility. Hospitals and pulmonary specialty clinics are increasingly utilizing advanced airway stabilization devices to manage tracheobronchial complications and post-surgical respiratory conditions. Strong collaboration between healthcare institutions and medical device manufacturers continues to support technological innovation and long-term development across the European Pulmonary Stents Industry Report landscape.

Germany Pulmonary Stents Market

Germany remains a highly influential market within Europe’s respiratory medical device sector and represented 31% of the regional pulmonary stents market . The country benefits from advanced healthcare infrastructure, strong clinical expertise in interventional pulmonology, and increasing demand for minimally invasive airway intervention procedures. Rising prevalence of chronic respiratory diseases, lung cancer, and airway obstruction disorders continues to support pulmonary stent adoption throughout German hospitals and specialty respiratory centers. Healthcare providers are actively investing in advanced bronchoscopy systems and customized airway management solutions to improve clinical outcomes.

The pulmonary stents market research report highlights Germany’s strong emphasis on medical technology innovation and precision-engineered respiratory devices. Manufacturers are developing pulmonary stents with improved airway conformity, durability, and patient comfort. Clinical research institutions and pulmonary healthcare providers are collaborating to advance next-generation airway stabilization technologies and improve procedural efficiency. Increasing awareness regarding advanced respiratory disease management and strong reimbursement support further contribute to market expansion. Germany’s leadership in healthcare innovation and respiratory intervention technologies continues strengthening its role within the broader Pulmonary Stents industry analysis.

United Kingdom Pulmonary Stents Market

The United Kingdom continues to experience strong demand within the pulmonary stents market due to growing respiratory disease burden and increasing focus on advanced airway intervention procedures. The country accounted for 21% of the European pulmonary stents market , supported by expanding adoption of bronchoscopy-guided pulmonary treatments across healthcare institutions. Rising incidence of tracheal stenosis, chronic obstructive pulmonary disease, and malignant airway obstruction is contributing to increased utilization of pulmonary stents within hospitals and specialty respiratory care centers.

The pulmonary stents market Analysis indicates that healthcare providers across the United Kingdom are emphasizing minimally invasive pulmonary procedures that improve recovery times and reduce hospitalization periods. Medical device manufacturers are introducing innovative pulmonary stents designed to enhance airway flexibility, minimize migration risks, and improve patient safety. Growing investments in respiratory healthcare infrastructure and increasing awareness regarding early diagnosis of airway disorders continue supporting market growth. The country’s advanced healthcare system and active participation in clinical respiratory research programs further strengthen development opportunities within the pulmonary stents market forecast.

Asia-Pacific

Asia-Pacific is emerging as one of the fastest-growing regions in the pulmonary stents market due to expanding healthcare infrastructure, increasing respiratory disease prevalence, and rising healthcare expenditure. The region captured 25% of the global pulmonary stents market share, supported by growing demand for advanced airway management technologies across major economies including China, Japan, and India. Increasing urban pollution, smoking prevalence, and rising cases of chronic respiratory conditions continue driving pulmonary intervention procedures throughout the region.

The pulmonary stents market trends reveal substantial investment in respiratory healthcare modernization and expansion of specialty pulmonary treatment facilities across Asia-Pacific. Hospitals are increasingly adopting advanced bronchoscopy systems and minimally invasive airway stabilization technologies to improve respiratory care outcomes. Manufacturers are strengthening regional production capabilities and distribution partnerships to meet rising demand for pulmonary stents and respiratory intervention devices. Increasing healthcare awareness, expanding medical tourism activities, and growing adoption of technologically advanced pulmonary treatment solutions continue supporting long-term regional market development.

Japan Pulmonary Stents Market

Japan remains a major contributor to the Asia-Pacific pulmonary stents market and represented 19% of the regional market. The country’s highly developed healthcare system, aging population, and strong emphasis on advanced respiratory disease management continue driving pulmonary stent adoption. Hospitals and pulmonary specialty centers are actively utilizing advanced bronchoscopy-guided interventions to treat airway obstruction disorders, tracheal stenosis, and post-surgical respiratory complications.

The pulmonary stents market Insights indicate that Japanese medical device manufacturers are heavily focused on precision engineering, patient safety, and innovative airway management technologies. Increasing clinical research activities related to minimally invasive respiratory procedures and next-generation pulmonary stents continue supporting market expansion. Healthcare providers are emphasizing personalized treatment strategies and advanced airway stabilization devices to improve long-term respiratory outcomes. Strong investment in healthcare technology and increasing demand for high-quality pulmonary intervention systems continue reinforcing Japan’s leadership position within the regional Pulmonary Stents Industry Report.

China Pulmonary Stents Market

China remains the largest contributor within the Asia-Pacific pulmonary stents market and held 4% of the regional market share. Rapid healthcare infrastructure development, increasing prevalence of respiratory disorders, and rising adoption of advanced airway intervention technologies continue supporting strong market expansion throughout the country. Urban pollution, smoking-related respiratory diseases, and increasing awareness regarding minimally invasive pulmonary procedures are creating substantial demand for pulmonary stents across hospitals and respiratory specialty centers.

The pulmonary stents market growth in China is further supported by government healthcare modernization initiatives and rising investment in respiratory disease management programs. Domestic manufacturers are expanding production capabilities and focusing on innovative pulmonary stent technologies designed to improve airway stabilization and patient comfort. International medical device companies are also strengthening partnerships and distribution networks within the Chinese healthcare market. Increasing healthcare accessibility, growing pulmonary care awareness, and expanding use of advanced bronchoscopy technologies continue positioning China as a major growth engine within the global Pulmonary Stents industry analysis.

Rest of World

The Rest of World region continues to experience gradual expansion within the pulmonary stents market due to improving healthcare infrastructure and increasing awareness regarding advanced respiratory treatment options. The region contributed 8% of the global pulmonary stents market , supported by rising adoption of minimally invasive airway management procedures across Latin America, the Middle East, and Africa. Increasing prevalence of respiratory diseases and growing access to specialized pulmonary care services are creating new opportunities for pulmonary stent manufacturers.

The pulmonary stents market opportunities landscape within emerging economies is being strengthened by healthcare modernization initiatives and rising investment in specialty respiratory treatment facilities. Hospitals and pulmonary care centers are increasingly adopting advanced bronchoscopy systems and airway stabilization technologies to improve patient outcomes. Medical device companies are expanding regional distribution networks and introducing cost-effective pulmonary stent solutions tailored for developing healthcare systems. Increasing collaboration between international manufacturers and local healthcare providers continues supporting long-term development across the Rest of World Pulmonary Stents Industry.

List of Top Pulmonary Stents Companies

• Bess medizintechnik GmbH
• Boston Scientific Corporation
• Cook Group
• E. Benson Hood Laboratories Inc.
• Efer Endoscopy
• Endo-Flex GmbH
• Merit Medical Systems Inc.
• Micro-Tech (Nanjing) Co. Ltd
• Standard Sci Tech Inc.
• Olympus Corporation

Top Two Companies with Highest Market Share

• Boston Scientific Corporation – 18%
• Olympus Corporation – 14%

Investment Analysis and Opportunities

The pulmonary stents market opportunities landscape is attracting increasing investment from medical device manufacturers, healthcare institutions, and research organizations. Investments are focused on development of advanced pulmonary stents with improved flexibility, anti-migration capabilities, and enhanced biocompatibility. Companies are also investing in bronchoscopy technologies and precision-guided respiratory intervention systems to improve procedural efficiency.

Emerging markets represent significant investment opportunities due to expanding healthcare infrastructure and rising respiratory disease prevalence. Strategic partnerships between respiratory care centers and medical device companies are accelerating commercialization of innovative pulmonary stent technologies. Investments in bioresorbable airway stents and personalized respiratory devices are expected to create new revenue streams within the pulmonary stents market research report ecosystem. Increasing demand for minimally invasive pulmonary procedures further supports long-term investment potential.

New Product Development

New product development remains a critical focus within the pulmonary stents market Analysis. Manufacturers are introducing pulmonary stents with enhanced flexibility, reduced migration risk, and improved airway conformity. Hybrid pulmonary stents combining metal and silicone technologies are gaining popularity due to improved patient outcomes and procedural performance.

Research activities are increasingly focused on bioresorbable pulmonary stents that gradually dissolve after airway healing is achieved. Drug-eluting pulmonary stents designed to minimize inflammation and tissue overgrowth are also under development. Advanced imaging integration and patient-specific airway modeling technologies are improving precision during pulmonary stent placement procedures. Manufacturers are further emphasizing lightweight materials, anti-bacterial coatings, and customized airway stabilization solutions. These innovations are expected to strengthen competitive positioning across the global pulmonary stents industry.

Five Recent Developments (2023–2025)

• Boston Scientific Corporation expanded its respiratory intervention device portfolio with advanced airway management technologies.
• Olympus Corporation enhanced bronchoscopy system integration capabilities for pulmonary stent procedures.
• Merit Medical Systems Inc. increased investment in minimally invasive pulmonary intervention technologies.
• Micro-Tech (Nanjing) Co. Ltd expanded manufacturing capabilities for advanced respiratory stent devices.
• Multiple manufacturers accelerated research into bioresorbable and hybrid pulmonary stent technologies for complex airway conditions.

Report Coverage

The pulmonary stents market Report provides detailed analysis of market trends, segmentation, competitive landscape, technological advancements, and regional developments influencing the global respiratory medical device industry. The report evaluates key growth drivers, restraints, opportunities, and challenges impacting pulmonary stent adoption across hospitals, specialty clinics, and respiratory care centers.

Request for Customization   to gain extensive market insights.

Comprehensive segmentation analysis covers self-expandable and balloon-expandable pulmonary stents along with application categories including metal, silicon, hybrid, tracheobronchial, and laryngeal stents. Regional outlook analysis evaluates North America, Europe, Asia-Pacific, and Rest of World markets while highlighting country-level developments in Germany, the United Kingdom, Japan, and China.The report further examines investment trends, product innovation strategies, regulatory developments, and competitive positioning among leading pulmonary stent manufacturers. Detailed pulmonary stents market Insights support strategic planning and business expansion initiatives for healthcare providers, investors, distributors, and medical device companies.